sharecast

{{ storiesRelated.title }}

Full List Of Stories
18 Nov
dl xps pensions group plc xps financials financial services investment banking and brokerage services investment services ftse logo 20240620 1226
Broker tips: XPS Pensions, John Wood Group

RBC Capital Markets lifted its price target on XPS Pensions on Monday to 395. 0p from 355. 0p ahead of first-half results.

18 Nov
dl city of london bank junction underground financial london stock exchange street pb
Director dealings: McBride chairman raises stake

McBride revealed on Monday that chairman Jeff Nodland had acquired 50,000 ordinary shares in the London-listed manufacturer.

18 Nov
dl wall street new york city wall st nyc new york stock exchange nyse nasdaq us usa united states of america trading finance unsplash
US open: Stocks mixed following last week's heavy losses

Wall Street trading got off to a mixed start on Monday after major indices turned in their worst weekly performance in two months last week.

18 Nov
house dl us home housing construction
NAHB housing market index rises to 46 in November

The National Association of Home Builders/Wells Fargo housing market index rose to 46 in November, up from 43 in October.

18 Nov
dl spirit airlines airline us usa united states of america aircraft plane travel pd
Spirit Airlines files for Chapter 11 bankruptcy protection

Budget carrier Spirit Airlines has filed for Chapter 11 bankruptcy protection as it looks to restructure its debt after merger talks with Frontier collapsed.

18 Nov
dl nyse new york stock exchange wall st street city finance dow jones nasdaq sp finance dollar dollars us usa united states of america
US pre-open: Futures mixed as investors await Q3 retail earnings

Wall Street futures were mixed ahead of the bell on Monday as investors awaited more Q3 earnings reports.

18 Nov
dl john wood group plc ftse 250 energy oil gas and coal oil equipment and services logo 20230112
Berenberg lowers target price on John Wood

Analysts at Berenberg slashed their target price on engineering and consulting business John Wood Group from 150. 0p to 60. 0p on Monday, stating an independent review into its projects business had created "substantial uncertainty".

18 Nov
dl tesla logo badge electric vehicles cars ev elon musk unsplash
Tesla shares surge as Trump looks to establish Federal framework for fully self-driving cars

Shares in electric carmaker Tesla surged ahead of the bell on Monday following news that president-elect Donald Trump would look to establish a federal framework for fully self-driving vehicles and make it the Department of Transportation's priority number one.

18 Nov
dl mediazest plc aim media zest consumer discretionary media agencies logo 20230116
MediaZest completes installation of 'proof of concept' project

Audio-visual solutions provider MediaZest said on Monday that it has completed installation for an initial "proof of concept" project to supply digital currency boards in 50 UK Post Office branches.

18 Nov
dl trufin plc aim tru fin financials financial services finance and credit services consumer lending logo 20230120
TruFin turns EBITDA positive, FY revenues surge

Financial services firm TruFin said on Monday that full-year revenues were expected to be "significantly ahead of market expectations", driven by a "strong performance" from both the console and mobile divisions of Playstack.

18 Nov
dl begbies traynor group plc aim financials financial services investment banking and brokerage services diversified financial services logo
Begbies Traynor delivers 'strong financial performance' in H1

Corporate restructuring firm Begbies Traynor said on Monday that it had delivered a "strong financial performance" throughout H1, with double-digit revenue and profit growth.

18 Nov
dl astrazeneca plc azn health care healthcare pharmaceuticals and biotechnology pharmaceuticals ftse 100 premium astra zeneca 20230327 1835
AstraZeneca's Tagrisso recommended for EU approval

Drugmaker AstraZeneca said on Monday that its Tagrisso asset had received a recommendation for EU approval on the back of LAURA Phase III trial results, which revealed it had extended median progression-free survival to more than three years.